Non invasive edge Position Kaligia’s non-invasive lightwave biosensors as a premium alternative to invasive testing, targeting hospitals, clinics, and ambulatory centers seeking faster, more comfortable patient experiences and reduced procedure-related risks.

Strategic partnerships Leverage current collaborations with Tampa General Hospital, AdventHealth, USF and related academic partners to accelerate pilots, validation studies, and co-development opportunities that can be expanded to additional health systems.

COVID screening Highlight ongoing use cases for rapid COVID-19 screening and biochemistry-based vitals monitoring to tap into hospital infection control programs, occupational health services, and public health partnerships.

Early stage scale With a small team and revenue under one million, target early adopters in large healthcare networks and reference accounts to build case studies, refine the platform, and justify broader procurement through value-based ROI.

Platform value Emphasize the Good Health platform’s ability to transform diagnostics from reactive to proactive care, offering cross-selling opportunities for tied services, analytics, and ongoing monitoring contracts to drive customer lifetime value.